Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

Nystatin Topical Powder

&times

Overview

What is Nystatin Topical Powder?

Nystatin is a polyene antifungal antibiotic obtained from The molecular formula for Nystatin is CHNO. The molecular weight of Nystatin is 926.09.

Structural formula:

Nystatin topical powder is for dermatologic use.

Nystatin topical powder contains 100,000 USP nystatin units per gram dispersed in talc.



What does Nystatin Topical Powder look like?



What are the available doses of Nystatin Topical Powder?

Sorry No records found.

What should I talk to my health care provider before I take Nystatin Topical Powder?

Sorry No records found

How should I use Nystatin Topical Powder?

Nystatin topical powder is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by and other susceptible species.

Nystatin topical powder is not indicated for systemic, oral, intravaginal or ophthalmic use.

Very moist lesions are best treated with the topical dusting powder.


What interacts with Nystatin Topical Powder?

Nystatin topical powder is contraindicated in patients with a history of hypersensitivity to of its components.



What are the warnings of Nystatin Topical Powder?

Sorry No Records found


What are the precautions of Nystatin Topical Powder?

General

Nystatin topical powder should not be used for the treatment of systemic, oral, intravaginal or ophthalmic infections.

If irritation or sensitization develops, treatment should be discontinued and appropriate measures taken as indicated. It is recommended that KOH smears, cultures, or other diagnostic methods be used to confirm the diagnosis of cutaneous or mucocutaneous candidiasis and to rule out infection caused by other pathogens.

Information for Patients

Patients using this medication should receive the following information and instructions:1. The patient should be instructed to use this medication as directed (including the replacement of missed doses). This medication is not for any disorder other than that for which it is prescribed.2. Even if symptomatic relief occurs within the first few days of treatment, the patient should be advised not to interrupt or discontinue therapy until the prescribed course of treatment is completed.3. If symptoms of irritation develop, the patient should be advised to notify the physician promptly.

Laboratory Tests

If there is a lack of therapeutic response, KOH smears, cultures, or other diagnostic methods should be repeated.

Carcinogenesis, Mutagenesis, Impairment of Fertility

No long-term animal studies have been performed to evaluate the carcinogenic potential of nystatin. No studies have been performed to determine the mutagenicity of nystatin or its effects on male or female fertility.

Pregnancy

Array

Array

Animal reproduction studies have not been conducted with any nystatin topical preparation. It also is not known whether these preparations can cause fetal harm when used by a pregnant woman or can affect reproductive capacity. Nystatin topical powder should be prescribed for a pregnant woman only if the potential benefit to the mother outweighs the potential risk to the fetus.

Nursing Mothers

It is not known whether nystatin is excreted in human milk. Caution should be exercised when nystatin is prescribed for a nursing woman.

Pediatric Use

Safety and effectiveness have been established in the pediatric population from birth to 16 years. (See ).

Geriatric Use

Clinical studies with nystatin topical powder did not include sufficient numbers of subjects aged 65 years and older to determine whether they respond differently than younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.


What are the side effects of Nystatin Topical Powder?

The frequency of adverse events reported in patients using nystatin topical powder is less than 0.1%. The more common events that were reported include allergic reactions, burning, itching, rash, eczema, and pain on application. (See .)


What should I look out for while using Nystatin Topical Powder?

Nystatin topical powder is contraindicated in patients with a history of hypersensitivity to of its components.

Drug Interactions

Array

WARNINGS


What might happen if I take too much Nystatin Topical Powder?

Sorry No Records found


How should I store and handle Nystatin Topical Powder?

Store at controlled room temperature 20° to 25°C (68° to 77°F) [see USP].Nystatin topical powder, USP is supplied as 100,000 units nystatin per gram in plastic squeeze bottles.15 g (NDC 42806-178-15) 30 g (NDC 42806-178-30) 60 g (NDC 42806-178-60) Nystatin topical powder, USP is supplied as 100,000 units nystatin per gram in plastic squeeze bottles.15 g (NDC 42806-178-15) 30 g (NDC 42806-178-30) 60 g (NDC 42806-178-60) Nystatin topical powder, USP is supplied as 100,000 units nystatin per gram in plastic squeeze bottles.15 g (NDC 42806-178-15) 30 g (NDC 42806-178-30) 60 g (NDC 42806-178-60) Nystatin topical powder, USP is supplied as 100,000 units nystatin per gram in plastic squeeze bottles.15 g (NDC 42806-178-15) 30 g (NDC 42806-178-30) 60 g (NDC 42806-178-60)


&times

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

Nystatin is not absorbed from intact skin or mucous membrane.

Non-Clinical Toxicology
Nystatin topical powder is contraindicated in patients with a history of hypersensitivity to of its components.

Array

Nystatin topical powder should not be used for the treatment of systemic, oral, intravaginal or ophthalmic infections.

If irritation or sensitization develops, treatment should be discontinued and appropriate measures taken as indicated. It is recommended that KOH smears, cultures, or other diagnostic methods be used to confirm the diagnosis of cutaneous or mucocutaneous candidiasis and to rule out infection caused by other pathogens.

The frequency of adverse events reported in patients using nystatin topical powder is less than 0.1%. The more common events that were reported include allergic reactions, burning, itching, rash, eczema, and pain on application. (See .)

&times

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

&times

Review

Rate this treatment and share your opinion


Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

This medication has worked for me.




This medication has been easy for me to use.




Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
&times

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
&times

Tips

Tips

&times

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).